Celebrating our Contribution to Advancing Nuclear Medicine for the World HAMILTON, ON, March 19, 2024 – The Centre for Probe Development and Commercialization (CPDC), a global leader in the development and commercialization of radiopharmaceuticals, is proud to celebrate its 16th anniversary today. Since 2008, CPDC has been at the forefront of advancing nuclear medicine for … Read more
Significant Milestone on the Path to Submission for Canadian Regulatory Approval in Late 2024 HAMILTON, ON, March 13, 2024 – The Centre for Probe Development and Commercialization (CPDC), a global leader in the development and commercialization of radiopharmaceuticals, today announced the closure of the Canadian Phase 3 trial for [18F]PSMA-1007. [18F]PSMA-1007 is a positron-emitting tomography … Read more
HAMILTON, ON, July 29, 2024 – The Centre for Probe Development and Commercialization (CPDC), a global leader in radiopharmaceutical development and commercialization, today announced that its Founder, John Valliant, Ph.D., has stepped down from its Board of Directors. Dr. Valliant established CPDC in 2008 as a Centre of Excellence for the Commercialization of Research in … Read more